GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect
GLP-1 drugs must now carry a warning label about a potential link to a rare eye condition that can result in vision loss, the U.S. Food and Drug Administration announced on Nov. 9. 2026. The eye condition is called non-arteritic anterior ischemic optic neuropathy, or NAION, and doctors often refer…
The Conversation ·